Erik Dawson

Erik Dawson holds extensive experience in quality management and regulatory affairs, currently serving as the Head of Quality and Management Representative at Accelerate Diagnostics since April 2022, where responsibilities include supporting In Vitro Diagnostic devices and leading QMS remediation efforts. Prior to this role, Erik Dawson spent nearly two decades at Philips, progressing through various positions, including Senior Regulatory Affairs Program Manager, where achievements included leading EU MDR labeling remediation, and Quality System Engineer, supporting training and quality management systems. Erik Dawson's diverse expertise encompasses QMS deployment, regulatory compliance, data management, and process improvement, contributing to significant successes in product development and regulatory operations across multiple healthcare sectors.